Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To observe the long-term safety of filgotinib in subjects who have completed or met protocol specified efficacy discontinuation criteria in a prior Gilead-sponsored filgotinib treatment study in CD
Critère d'inclusion
- Moderately to Severely Active Crohn's Disease (CD)